COMMUNIQUÉS West-GlobeNewswire

Misonix to Report Fiscal 2019 Third Quarter Financial Results and Host Conference Call and Webcast on May 8
10/04/2019
FARMINGDALE, N.Y., April 10, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Tauriga Sciences Inc. Executes Distribution Agreement with Prolific South Florida Based Medical Practice Management Firm
10/04/2019
New York, NY, April 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA
10/04/2019
EAST RUTHERFORD, N.J., April 10, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
Samumed Announces Multiple Presentations at the 19th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
10/04/2019
Poster with new data from a recently completed phase 2b trial of SM04690 for the treatment of knee osteoarthritis highlights the effects of saline placebo injections versus sham injections SAN DIEGO, April 10, 2019 ( [...]
Avinger Receives FDA Clearance of Pantheris SV Device
10/04/2019
Expands Addressable Market by Allowing for Treatment of Small Vessel Disease REDWOOD CITY, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of image-guided, catheter-based [...]
Entasis Therapeutics Announces Multiple Data Presentations at ECCMID 2019
10/04/2019
CEO Manos Perros, PhD to present on Industry Panel “Therapeutics Pipeline Corner” on April 14 WALTHAM, Mass., April 10, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage [...]
Syapse Oncology Platform Achieves HITRUST CSF® Certification
10/04/2019
Certification demonstrates the company's dedication to best practices and its determination to provide the highest level of information security for its health system customers SAN FRANCISCO, April 10, 2019 (GLOBE [...]
Zealand Pharma grants new warrants under employee warrant program
10/04/2019
Company announcement – No. 13 / 2019 Zealand Pharma grants new warrants under employee warrant program Copenhagen, April 10, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) announces the [...]
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and 510(k) Clearance of the PoNS™ Device
10/04/2019
NEWTOWN, Pa., April 10, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that the U.S [...]
Idera Pharmaceuticals Provides Corporate Update
10/04/2019
EXTON, Pa., April 10, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of [...]
Wave Life Sciences Provides Timing Update on PRECISION-HD Clinical Programs
10/04/2019
Topline data readout from Huntington’s disease clinical trials now expected by year end 2019 CAMBRIDGE, Mass., April 10, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage genetic medicines [...]
CB2 Insights Completes Acquisition of Cannabis Evaluation Clinics in Arizona and Colorado
10/04/2019
Acquisition further strengthens medical cannabis data company’s financial metrics and data asset; reaching more than 85,000 patient evaluations per year TORONTO, April 10, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (“CB2” or [...]
Ravenquest Provides Update on Recent License and Production Capacity Expansion
10/04/2019
VANCOUVER, British Columbia, April 10, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”) a federally licensed producer of cannabis, is pleased to [...]
Professor Alvaro Pascual-Leone joins Nexstim Scientific Advisory Board
10/04/2019
Press release, Helsinki, 10 April 2019 at 9.00 am (EET) Professor Alvaro Pascual-Leone joins Nexstim Scientific Advisory Board Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and [...]
Centauri Therapeutics to present at 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
10/04/2019
Centauri Therapeutics to present at 29 th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) UK, 10 April 2019: Centauri Therapeutics (“Centauri”), an immunotherapy company active in oncology [...]
Oasmia expands the Management Team
10/04/2019
Oasmia Pharmaceutical AB (NASDAQ: OASM) expands the Management Team in order to directly involve the whole organization in the commercialization of Apealea and other product candidates. Earlier the Management Team was [...]
EssilorLuxottica: 2018 Registration Document Filed
10/04/2019
2018 Registration Document Filed Charenton-Le-Pont, France (April 10, 2019 – 8:00 am CEST) – The 2018 EssilorLuxottica Registration Document was filed in French version with the Autorité des Marchés Financiers (AMF) on [...]
EssilorLuxottica : Mise à disposition du Document de référence 2018
10/04/2019
Mise à disposition du Document de référence 2018 Charenton-le-Pont, France (le 10 avril 2019 – 8h00) - Le Document de référence 2018 d’EssilorLuxottica a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 9 [...]
William Demant Holding A/S: Investor news - Demant is bringing Philips hearing aids to market
10/04/2019
Investor news 10 April 2019 Demant is bringing Philips hearing aids to market Hearing aid users can now choose solutions from the Philips brand portfolio, one of the world’s best known and leading health technology [...]

Pages